- 부서명 : 기획조정과
- 작성일 : 2021-05-14
- 조회수 : 109
- 출처: 세계보건기구(WHO)
WHO today listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light
for this vaccine to be rolled out globally. The Sinopharm vaccine is produced by Beijing Bio-Institute
of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).
“The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for
countries seeking to protect health workers and populations at risk,” said Dr Mariângela Simão,
WHO Assistant-Director General for Access to Health Products. “We urge the manufacturer to
participate in the COVAX Facility and contribute to the goal of more equitable vaccine distribution.”
☞ 자세한 사항은 내용바로가기를 통해 확인하실 수 있습니다.